{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T14:45:37Z","timestamp":1785422737545,"version":"3.56.0"},"reference-count":74,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:00:00Z","timestamp":1777420800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["316249678-SFB1279 (A07)"],"award-info":[{"award-number":["316249678-SFB1279 (A07)"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"award":["316249678-SFB1279 (A07)"],"award-info":[{"award-number":["316249678-SFB1279 (A07)"]}],"id":[{"id":"https:\/\/ror.org\/018mejw64","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Toxins"],"abstract":"<jats:p>The life-threatening disease pertussis, also known as whooping cough, is caused by a complex interplay of several virulence factors produced by the bacterium Bordetella (B.) pertussis. These include the AB-type protein toxin pertussis toxin (PT), the main causative agent of pertussis. After infection with B. pertussis, PT is released and binds to its human target cells, which internalize PT. The enzyme subunit of PT is then taken up into the cytosol, where it catalyzes the ADP-ribosylation of the \u03b1-subunit of inhibitory GTP-binding proteins from the G\u03b1i type. This ultimately leads to the development of the characteristic clinical symptoms associated with pertussis. Pertussis is a vaccine-preventable but highly infectious respiratory disease, and especially younger children are prone to develop severe pertussis. Despite the vaccination, over the past few years, increasing case numbers have been reported globally. Moreover, treatment options are strongly limited to antibiotics and symptomatic treatment. Therefore, novel therapies against toxin-mediated diseases are urgently required, while AB-type toxins such as PT are promising pharmacological targets to combat these associated diseases. To identify novel pharmacological inhibitors for AB-type toxins, huge potential lies within the human proteome\/peptidome. Endogenous protein or peptide inhibitors for bacterial toxins might have evolved as part of the innate immunity and are awaited to be discovered. The scientific community is committed to identify potential candidates through targeted screening or explorative hypothesis-driven approaches. This review summarizes the recent efforts in the identification and characterization of the human body\u2019s own proteins and peptides that inhibit PT. PT-inhibiting peptides were found by unbiased screening of peptide libraries from human hemofiltrate or hypothesis-driven evaluation, and PT-neutralizing mechanisms were discovered in cell-based approaches. The identification of endogenous peptides and proteins, e.g., defensins and \u03b11-antitrypsin, as potent inhibitors of PT paves the way towards the development of novel therapeutic options against pertussis.<\/jats:p>","DOI":"10.3390\/toxins18050208","type":"journal-article","created":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T08:03:47Z","timestamp":1777536227000},"page":"208","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The Battle Against Pertussis: Discovery of Endogenous Human Proteins and Peptides as Toxin-Inhibitors"],"prefix":"10.3390","volume":"18","author":[{"given":"Stefanie","family":"Lietz","sequence":"first","affiliation":[{"name":"Institute of Experimental and Clinical Pharmacology, Toxicology and Pharmacology of Natural Products, Ulm University Medical Center, 89081 Ulm, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holger","family":"Barth","sequence":"additional","affiliation":[{"name":"Institute of Experimental and Clinical Pharmacology, Toxicology and Pharmacology of Natural Products, Ulm University Medical Center, 89081 Ulm, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,4,29]]},"reference":[{"key":"ref_1","unstructured":"(2025, January 09). European Centre for Disease Prevention and Control Epidemiological Update: Diphtheria Cases in Europe. Available online: https:\/\/www.ecdc.europa.eu\/en\/news-events\/epidemiological-update-diphtheria-cases-europe."},{"key":"ref_2","unstructured":"European Centre for Disease Prevention and Control (2024). Increase of Pertussis Cases in the EU\/EEA: 8 May 2024, European Centre for Disease Prevention and Control."},{"key":"ref_3","unstructured":"Greenwood, D., Barer, M., Slack, R., and Irving, W. (2012). 13\u2014Bacterial Pathogenicity. Medical Microbiology, Churchill Livingstone. [8th ed.]."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.7150\/ijms.110104","article-title":"Bacterial Exotoxins in Medicine: Potential Value and Perspectives","volume":"22","author":"Xiao","year":"2025","journal-title":"Int. J. Med. Sci."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/nrmicro1150","article-title":"Bacterial Cytotoxins: Targeting Eukaryotic Switches","volume":"3","author":"Aktories","year":"2005","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.3201\/eid2706.203850","article-title":"Pertactin-Deficient Bordetella Pertussis, Vaccine-Driven Evolution, and Reemergence of Pertussis","volume":"27","author":"Ma","year":"2021","journal-title":"Emerg. Infect. Dis."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1128\/CMR.18.2.326-382.2005","article-title":"Molecular Pathogenesis, Epidemiology, and Clinical Manifestations of Respiratory Infections Due to Bordetella Pertussis and Other Bordetella Subspecies","volume":"18","author":"Mattoo","year":"2005","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Ernst, K. (2022). Novel Strategies to Inhibit Pertussis Toxin. Toxins, 14.","DOI":"10.3390\/toxins14030187"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"e2049","DOI":"10.7196\/SAJCC.2025.v41i1.2049","article-title":"Critical Pertussis Infection in the Paediatric Intensive Care Unit: A Case Series in an Outbreak","volume":"41","author":"Crichton","year":"2025","journal-title":"S. Afr. J. Crit. Care"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1136\/adc.2006.114082","article-title":"Pertussis Requiring Intensive Care","volume":"92","author":"Surridge","year":"2007","journal-title":"Arch. Dis. Child."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Lietz, S., and Barth, H. (Arch. Toxicol., 2026). Novel Endogenous Protein-Based Strategies to Inhibit Clinically Relevant Bacterial AB-Type Toxins Including Pertussis Toxin, Arch. Toxicol., online ahead of print.","DOI":"10.1007\/s00204-026-04372-5"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Scanlon, K., Skerry, C., and Carbonetti, N. (2019). Association of Pertussis Toxin with Severe Pertussis Disease. Toxins, 11.","DOI":"10.3390\/toxins11070373"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/5584_2019_403","article-title":"Role of Major Toxin Virulence Factors in Pertussis Infection and Disease Pathogenesis","volume":"1183","author":"Scanlon","year":"2019","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0969-2126(00)00007-1","article-title":"The Crystal Structure of Pertussis Toxin","volume":"2","author":"Stein","year":"1994","journal-title":"Structure"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"5516","DOI":"10.1021\/bi00265a021","article-title":"Subunit Structure of Islet-Activating Protein, Pertussis Toxin, in Conformity with the A-B Model","volume":"21","author":"Tamura","year":"1982","journal-title":"Biochemistry"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2970","DOI":"10.1073\/pnas.90.7.2970","article-title":"Molecular Characterization of an Operon Required for Pertussis Toxin Secretion","volume":"90","author":"Weiss","year":"1993","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"8677","DOI":"10.1016\/S0021-9258(18)68358-9","article-title":"Use of Glycosyltransferases to Restore Pertussis Toxin Receptor Activity to Asialoagalactofetuin","volume":"263","author":"Armstrong","year":"1988","journal-title":"J. Biol. Chem."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"3324","DOI":"10.1128\/iai.57.11.3324-3330.1989","article-title":"Binding of Pertussis Toxin to Eucaryotic Cells and Glycoproteins","volume":"57","author":"Witvliet","year":"1989","journal-title":"Infect. Immun."},{"key":"ref_19","first-page":"40","article-title":"Endocytosis and Retrograde Transport of Pertussis Toxin to the Golgi Complex as a Prerequisite for Cellular Intoxication","volume":"73","author":"Linnemann","year":"1997","journal-title":"Eur. J. Cell Biol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1111\/j.1462-5822.2007.01115.x","article-title":"Retrograde Transport of Pertussis Toxin in the Mammalian Cell","volume":"10","author":"Plaut","year":"2008","journal-title":"Cell. Microbiol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"3388","DOI":"10.1128\/IAI.00732-16","article-title":"Thermal Unfolding of the Pertussis Toxin S1 Subunit Facilitates Toxin Translocation to the Cytosol by the Mechanism of Endoplasmic Reticulum-Associated Degradation","volume":"84","author":"Banerjee","year":"2016","journal-title":"Infect. Immun."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"13734","DOI":"10.1021\/bi061175+","article-title":"The Pertussis Toxin S1 Subunit Is a Thermally Unstable Protein Susceptible to Degradation by the 20S Proteasome","volume":"45","author":"Pande","year":"2006","journal-title":"Biochemistry"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Ernst, K., Eberhardt, N., Mittler, A.-K., Sonnabend, M., Anastasia, A., Freisinger, S., Schiene-Fischer, C., Male\u0161evi\u0107, M., and Barth, H. (2018). Pharmacological Cyclophilin Inhibitors Prevent Intoxication of Mammalian Cells with Bordetella Pertussis Toxin. Toxins, 10.","DOI":"10.3390\/toxins10050181"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"5429","DOI":"10.1038\/s41598-021-84817-2","article-title":"Pharmacological Targeting of Host Chaperones Protects from Pertussis Toxin in Vitro and in Vivo","volume":"11","author":"Ernst","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"e13074","DOI":"10.1111\/cmi.13074","article-title":"A Binding Motif for Hsp90 in the A Chains of ADP-Ribosylating Toxins That Move from the Endoplasmic Reticulum to the Cytosol","volume":"21","author":"Kellner","year":"2019","journal-title":"Cell. Microbiol."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Kellner, A., Cherubin, P., Harper, J.K., and Teter, K. (2021). Proline Isomerization as a Key Determinant for Hsp90-Toxin Interactions. Front. Cell. Infect. Microbiol., 11.","DOI":"10.3389\/fcimb.2021.771653"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1016\/S0021-9258(18)32881-3","article-title":"Identification of the Predominant Substrate for ADP-Ribosylation by Islet Activating Protein","volume":"258","author":"Bokoch","year":"1983","journal-title":"J. Biol. Chem."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"3129","DOI":"10.1073\/pnas.79.10.3129","article-title":"Direct Modification of the Membrane Adenylate Cyclase System by Islet-Activating Protein Due to ADP-Ribosylation of a Membrane Protein","volume":"79","author":"Katada","year":"1982","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Tang, Q., Chan, H.Y., Huang, Y., and Wong, Y.H. (2026). Mechanisms of Pertussis Toxin Action: ADP-Ribosylation and Its Role in Pertussis Pathogenesis. Toxins, 18.","DOI":"10.3390\/toxins18030148"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Hoonakker, M.E. (2021). In Vivo Models and In Vitro Assays for the Assessment of Pertussis Toxin Activity. Toxins, 13.","DOI":"10.3390\/toxins13080565"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"107950","DOI":"10.1016\/j.jbc.2024.107950","article-title":"Alpha-1 Antitrypsin Inhibits Pertussis Toxin","volume":"300","author":"Lietz","year":"2024","journal-title":"J. Biol. Chem."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Nowakowska-Go\u0142acka, J., Sominka, H., Sowa-Rogozi\u0144ska, N., and S\u0142omi\u0144ska-Wojew\u00f3dzka, M. (2019). Toxins Utilize the Endoplasmic Reticulum-Associated Protein Degradation Pathway in Their Intoxication Process. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20061307"},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Teter, K. (2019). Intracellular Trafficking and Translocation of Pertussis Toxin. Toxins, 11.","DOI":"10.3390\/toxins11080437"},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Ivaska, L., Barkoff, A.-M., Mertsola, J., and He, Q. (2022). Macrolide Resistance in Bordetella Pertussis: Current Situation and Future Challenges. Antibiotics, 11.","DOI":"10.3390\/antibiotics11111570"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"966","DOI":"10.3201\/eid1806.120091","article-title":"Macrolide-Resistant Bordetella Pertussis Infection in Newborn Girl, France","volume":"18","author":"Guillot","year":"2012","journal-title":"Emerg. Infect. Dis."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"e25","DOI":"10.1017\/S0950268826101010","article-title":"Antimicrobial Resistance in Bordetella Pertussis: A Systematic Review and Meta-Analysis","volume":"154","author":"Ma","year":"2026","journal-title":"Epidemiol. Infect."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1056\/NEJMoa1200850","article-title":"Waning Protection after Fifth Dose of Acellular Pertussis Vaccine in Children","volume":"367","author":"Klein","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1017\/S0950268813000071","article-title":"Pertussis Resurgence: Waning Immunity and Pathogen Adaptation\u2014Two Sides of the Same Coin","volume":"142","author":"Mooi","year":"2014","journal-title":"Epidemiol. Infect."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"e1047","DOI":"10.1542\/peds.2012-1928","article-title":"Waning Immunity to Pertussis Following 5 Doses of DTaP","volume":"131","author":"Tartof","year":"2013","journal-title":"Pediatrics"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0025-5564(00)00009-2","article-title":"Waning Immunity and Sub-Clinical Infection in an Epidemic Model: Implications for Pertussis in The Netherlands","volume":"164","author":"Schellekens","year":"2000","journal-title":"Math. Biosci."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1016\/j.bmc.2017.10.038","article-title":"Exploiting the Human Peptidome for Novel Antimicrobial and Anticancer Agents","volume":"26","author":"Bosso","year":"2018","journal-title":"Bioorg. Med. Chem."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/s41392-024-02107-5","article-title":"Advance in Peptide-Based Drug Development: Delivery Platforms, Therapeutics and Vaccines","volume":"10","author":"Xiao","year":"2025","journal-title":"Sig. Transduct. Target. Ther."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Kling, C., Pulliainen, A.T., Barth, H., and Ernst, K. (2021). Human Peptides \u03b1-Defensin-1 and -5 Inhibit Pertussis Toxin. Toxins, 13.","DOI":"10.3390\/toxins13070480"},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Kling, C., Sommer, A., Almeida-Hernandez, Y., Rodr\u00edguez, A., Perez-Erviti, J.A., Bhadane, R., St\u00e4ndker, L., Wiese, S., Barth, H., and Pupo-Meri\u00f1o, M. (2023). Inhibition of Pertussis Toxin by Human \u03b1-Defensins-1 and -5: Differential Mechanisms of Action. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms241310557"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/j.humimm.2013.05.008","article-title":"Defensins: Natural Component of Human Innate Immunity","volume":"74","author":"Jarczak","year":"2013","journal-title":"Hum. Immunol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1007\/s12602-024-10436-8","article-title":"Human Defensins: Structure, Function, and Potential as Therapeutic Antimicrobial Agents with Highlights Against SARS CoV-2","volume":"17","author":"Nagib","year":"2025","journal-title":"Probiotics Antimicrob. Proteins"},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"O\u2019Brien, M.E., Murray, G., Gogoi, D., Yusuf, A., McCarthy, C., Wormald, M.R., Casey, M., Gabillard-Lefort, C., McElvaney, N.G., and Reeves, E.P. (2022). A Review of Alpha-1 Antitrypsin Binding Partners for Immune Regulation and Potential Therapeutic Application. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23052441"},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Schl\u00f6mmer, C., Brandtner, A., and Bachler, M. (2021). Antithrombin and Its Role in Host Defense and Inflammation. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22084283"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/bs.pmbts.2019.02.004","article-title":"The Clinical Use of Fondaparinux: A Synthetic Heparin Pentasaccharide","volume":"163","author":"Zhang","year":"2019","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"5987","DOI":"10.1007\/s00210-025-04744-1","article-title":"An Endogenous Human Peptide Derived from A1-Antitrypsin as a Novel Pharmacological Inhibitor of Bordetella Pertussis Toxin","volume":"399","author":"Lietz","year":"2025","journal-title":"Naunyn-Schmiedeberg\u2019s Arch. Pharmacol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.cell.2007.02.042","article-title":"Discovery and Optimization of a Natural HIV-1 Entry Inhibitor Targeting the Gp41 Fusion Peptide","volume":"129","author":"Adermann","year":"2007","journal-title":"Cell"},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Barthold, L., Heber, S., Schmidt, C.Q., Gradl, M., Weidinger, G., Barth, H., and Fischer, S. (2022). Human \u03b1-Defensin-6 Neutralizes Clostridioides Difficile Toxins TcdA and TcdB by Direct Binding. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23094509"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"fty022","DOI":"10.1093\/femspd\/fty022","article-title":"Human Alpha-Defensin-1 Protects Cells from Intoxication with Clostridium Perfringens Iota Toxin","volume":"76","author":"Fischer","year":"2018","journal-title":"Pathog. Dis."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"6244","DOI":"10.1096\/fj.201902816R","article-title":"Human Peptide \u03b1-Defensin-1 Interferes with Clostridioides Difficile Toxins TcdA, TcdB, and CDT","volume":"34","author":"Fischer","year":"2020","journal-title":"FASEB J."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1053\/j.gastro.2008.03.008","article-title":"Human \u03b1-Defensins Inhibit Clostridium Difficile Toxin B","volume":"134","author":"Giesemann","year":"2008","journal-title":"Gastroenterology"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"4830","DOI":"10.1073\/pnas.0500508102","article-title":"Human \u03b1-Defensins Neutralize Anthrax Lethal Toxin and Protect against Its Fatal Consequences","volume":"102","author":"Kim","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1042\/BJ20060425","article-title":"Human \u03b1-Defensins Neutralize Toxins of the Mono-ADP-Ribosyltransferase Family","volume":"399","author":"Kim","year":"2006","journal-title":"Biochem. J."},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Korbmacher, M., Fischer, S., Landenberger, M., Papatheodorou, P., Aktories, K., and Barth, H. (2020). Human \u03b1-Defensin-5 Efficiently Neutralizes Clostridioides Difficile Toxins TcdA, TcdB, and CDT. Front. Pharmacol., 11.","DOI":"10.3389\/fphar.2020.01204"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.tim.2006.08.001","article-title":"Defensin: A Multifunctional Molecule Lives up to Its Versatile Name","volume":"14","author":"Kim","year":"2006","journal-title":"Trends Microbiol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/nri1180","article-title":"Defensins: Antimicrobial Peptides of Innate Immunity","volume":"3","author":"Ganz","year":"2003","journal-title":"Nat. Rev. Immunol."},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Chan, E.D., King, P.T., Bai, X., Schoffstall, A.M., Sandhaus, R.A., and Buckle, A.M. (2024). The Inhibition of Serine Proteases by Serpins Is Augmented by Negatively Charged Heparin: A Concise Review of Some Clinically Relevant Interactions. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25031804"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/0006-291X(83)90532-6","article-title":"The Isolation of a Clone for Human \u03b1 1-Antitrypsin and the Detection of \u03b1 1-Antitrypsin in mRNA from Liver and Leukocytes","volume":"116","author":"Rogers","year":"1983","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1056\/NEJMra1910234","article-title":"Alpha1-Antitrypsin Deficiency","volume":"382","author":"Strnad","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"3931","DOI":"10.1016\/S0021-9258(19)85615-6","article-title":"Kinetics of Association of Serine Proteinases with Native and Oxidized Alpha-1-Proteinase Inhibitor and Alpha-1-Antichymotrypsin","volume":"255","author":"Beatty","year":"1980","journal-title":"J. Biol. Chem."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1165\/rcmb.2002-0258OC","article-title":"Inhibition of Proteinase 3 by A1-Antitrypsin In Vitro Predicts Very Fast Inhibition In Vivo","volume":"29","author":"Duranton","year":"2003","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1038\/s41467-021-21972-0","article-title":"Alpha-1 Antitrypsin Inhibits TMPRSS2 Protease Activity and SARS-CoV-2 Infection","volume":"12","author":"Wettstein","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Kelly-Robinson, G.A., Reihill, J.A., Lundy, F.T., McGarvey, L.P., Lockhart, J.C., Litherland, G.J., Thornbury, K.D., and Martin, S.L. (2021). The Serpin Superfamily and Their Role in the Regulation and Dysfunction of Serine Protease Activity in COPD and Other Chronic Lung Diseases. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22126351"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1002\/cbic.201000442","article-title":"Mechanisms of Macromolecular Protease Inhibitors","volume":"11","author":"Farady","year":"2010","journal-title":"Chembiochem"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1146\/annurev.bi.52.070183.003255","article-title":"Human Plasma Proteinase Inhibitors","volume":"52","author":"Travis","year":"1983","journal-title":"Annu. Rev. Biochem."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"S280","DOI":"10.1513\/AnnalsATS.201507-468KV","article-title":"Well-Known and Less Well-Known Functions of Alpha-1 Antitrypsin. Its Role in Chronic Obstructive Pulmonary Disease and Other Disease Developments","volume":"13","author":"Janciauskiene","year":"2016","journal-title":"Ann. Am. Thorac. Soc."},{"key":"ref_71","unstructured":"Adam, M.P., Feldman, J., Mirzaa, G.M., Pagon, R.A., Wallace, S.E., and Amemiya, A. (1993). Alpha-1 Antitrypsin Deficiency. GeneReviews\u00ae, University of Washington."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1172\/JCI110360","article-title":"Replacement Therapy of Alpha 1-Antitrypsin Deficiency. Reversal of Protease-Antiprotease Imbalance within the Alveolar Structures of PiZ Subjects","volume":"68","author":"Gadek","year":"1981","journal-title":"J. Clin. Investig."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"21257","DOI":"10.1038\/s41598-024-71706-7","article-title":"Alpha-1 Antitrypsin Inhibits Clostridium Botulinum C2 Toxin, Corynebacterium Diphtheriae Diphtheria Toxin and B. Anthracis Fusion Toxin","volume":"14","author":"Lietz","year":"2024","journal-title":"Sci. Rep."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s00018-025-05799-2","article-title":"The Antimicrobial Peptide Angie 5 Inhibits TcdA and TcdB from Clostridioides Difficile","volume":"82","author":"Lietz","year":"2025","journal-title":"Cell. Mol. Life Sci."}],"container-title":["Toxins"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6651\/18\/5\/208\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T04:22:35Z","timestamp":1778818955000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6651\/18\/5\/208"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,29]]},"references-count":74,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,5]]}},"alternative-id":["toxins18050208"],"URL":"https:\/\/doi.org\/10.3390\/toxins18050208","relation":{},"ISSN":["2072-6651"],"issn-type":[{"value":"2072-6651","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,29]]}}}